跳至主要内容
临床试验/NL-OMON27211
NL-OMON27211招募中不适用

Cerebrovascular reserve and white matter disease in patients with chronic anemia

AMC0 个研究点目标入组 140 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
AMC
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient group:
  • Sickle cell disease,
  • Thalassemia major, thalassemia intermedia, and HbH disease
  • 18 years of age or older
  • Informed consent
  • Control Group:
  • Either AS or AA haemogobin
  • 18 years of age or older
  • Informed consent

排除标准

  • Patient group:
  • Hospitalization in the past month for any reason
  • Inability of the patient to provide informed consent
  • Contraindications for MRI, such as claustrophobia or the presence of metal in the body
  • Sickle cell crisis at the moment of participation up to one month prior to participation
  • History of cerebral pathology that comprimized measeurements, such as cerebral palsy, brain tumour, meningitis, overt infrarct
  • Brain surgery performed in the last 3 months
  • ACZ contraindications
  • Severe liver, heart of renal dysfunction (clearance <10 mL/min)
  • Allgergy to sulphonamide
  • Pregnant or breastfeeding
  • Use of phenytoin, procaïne or acetylsacylic acid
  • Risk of hypokalaemia
  • Addison's disease
  • Severe asthma or emphysema
  • Control Group:
  • Any known chronic illness that may compromise subject safety or data integrity.
  • Vascular risk factors
  • Hypercholesterolemia
  • Contraindications for MRI
  • Contraindications for ACZ
  • Developmental delay, stroke, seizure disorder, or neurological conditions other than simple migraine
  • inability to cooperate with MRI examinations
  • Uncontrolled hypertension or history of hypertension

研究者

发起方
AMC

相似试验